N0018926RB011 - Drug Demand Reduction Program, Fentanyl/Norfentanyl Immunoassay Reagent Kits
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the Department of War's Drug Demand Reduction Program requiring FDA-approved and quality-managed immunoassay reagent kits specifically designed for detecting fentanyl and norfentanyl in human urine. These kits must be compatible with the existing Beckman Coulter AU5800 series systems used by the program. The procurement covers a five-year period, with an estimated usage capacity of up to 500,000 tests per month, ensuring a consistent supply to meet ongoing testing demands. Issued by the Naval Supply Fleet Logistics Center in Norfolk, Virginia, under solicitation number N0018926RB011, the contract is open for responses until June 26, 2026. The place of performance is Portsmouth, Virginia. The contract falls under NAICS code 325413, related to pharmaceutical manufacturing, and does not have any set-aside requirements. The primary point of contact for this procurement is Austin Waller, a contracting specialist, available for inquiries via email and phone.
General Info
Agency
NAICS
Place of Performance
Portsmouth, VA, 23708, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Department of War (DoW) Drug Demand Reduction Program (DDRP) has a requirement for Food & Drug Administration (FDA) and Quality Management Documented Fentanyl/Norfentanyl Immunoassay Reagent Kits for use with the currently installed Beckman Coulter AU5800 series systems. The reagents shall be capable of detecting fentanyl/norfentanyl in human urine samples.
The reagent kits are required for an ordering period of five (5) years. The estimated number of tests shall accommodate up to 500,000 tests per month.
Please see attached Statement of Work and copy of Solicitation N0018926RB011.
